Products billed under this code include Depo-Medrol, Methylprednisolone Acetate.
Payment limit per 1 MG, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Depo-Medrol | Pfizer Inc | 00009-0274-01 | 100 | $12.30 |
| Depo-Medrol | Pfizer Inc | 00009-0280-02 | 200 | $24.60 |
| Depo-Medrol | Pfizer Inc | 00009-0280-03 | 400 | $49.20 |
| Depo-Medrol | Pfizer Inc | 00009-0280-51 | 5000 | $615.00 |
| Depo-Medrol | Pfizer Inc | 00009-0280-52 | 10000 | $1,230.00 |
| Depo-Medrol | Pfizer Inc | 00009-0306-02 | 400 | $49.20 |
| Depo-Medrol | Pfizer Inc | 00009-0306-12 | 10000 | $1,230.00 |
| Depo-Medrol | Pfizer Inc | 00009-3073-01 | 40 | $4.92 |
| Depo-Medrol | Pfizer Inc | 00009-3073-03 | 1000 | $123.00 |
| Depo-Medrol | Pfizer Inc | 00009-3073-22 | 40 | $4.92 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Depo-Medrol | Pfizer Inc | 00009-3073-23 | 1000 | $123.00 |
| Depo-Medrol | Pfizer Inc | 00009-3475-01 | 80 | $9.84 |
| Depo-Medrol | Pfizer Inc | 00009-3475-03 | 2000 | $246.00 |
| Depo-Medrol | A-S Medication Solutions | 50090-0436-00 | 80 | $9.84 |
| Depo-Medrol | A-S Medication Solutions | 50090-0556-00 | 400 | $49.20 |
| Depo-Medrol | A-S Medication Solutions | 50090-1823-00 | 400 | $49.20 |
| Depo-Medrol | A-S Medication Solutions | 50090-2098-00 | 40 | $4.92 |
| Methylprednisolone Acetate | Sandoz Inc. | 00781-3516-75 | 400 | $49.20 |
| Methylprednisolone Acetate | Sandoz Inc. | 00781-3522-70 | 400 | $49.20 |
| Methylprednisolone Acetate | Sandoz Inc. | 00781-3522-75 | 200 | $24.60 |
| Methylprednisolone Acetate | Sagent Pharmaceuticals | 25021-0820-05 | 200 | $24.60 |
| Methylprednisolone Acetate | Sagent Pharmaceuticals | 25021-0820-10 | 400 | $49.20 |
| Methylprednisolone Acetate | Sagent Pharmaceuticals | 25021-0821-05 | 400 | $49.20 |
| Methylprednisolone Acetate | Endo USA, Inc. | 42023-0238-01 | 200 | $24.60 |
| Methylprednisolone Acetate | Endo USA, Inc. | 42023-0239-01 | 400 | $49.20 |
| Methylprednisolone Acetate | Endo USA, Inc. | 42023-0240-01 | 400 | $49.20 |
| Methylprednisolone Acetate | A-S Medication Solutions | 50090-5894-00 | 40 | $4.92 |
| Methylprednisolone Acetate | A-S Medication Solutions | 50090-6024-00 | 2000 | $246.00 |
| Methylprednisolone Acetate | Eugia US LLC | 55150-0313-01 | 400 | $49.20 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 60219-1573-01 | 40 | $4.92 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 60219-1573-05 | 1000 | $123.00 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 60219-1574-01 | 80 | $9.84 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 60219-1574-05 | 2000 | $246.00 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1552-05 | 2000 | $246.00 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1573-01 | 40 | $4.92 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1573-05 | 1000 | $123.00 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1574-01 | 80 | $9.84 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1574-05 | 2000 | $246.00 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1609-01 | 400 | $49.20 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1609-05 | 10000 | $1,230.00 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1610-01 | 400 | $49.20 |
| Methylprednisolone Acetate | Amneal Pharmaceuticals, LLC | 70121-1610-05 | 10000 | $1,230.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.123 | +$0.006 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.117 | +$0.005 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.112 | −$0.008 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.12 | +$0.001 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.119 | −$0.001 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $0.12 | +$0.01 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $0.11 | −$0.007 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $0.117 | −$0.002 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $0.119 | −$0.019 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $0.138 | +$0.004 | 1 MG | Inj, methylpred acetate 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $0.134 | – | 1 MG | Inj, methylpred acetate 1 mg | v1, posted March 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
